Regulatory approvals in California and Florida | 12-May-2023 | 07:00 | RNS |
Preliminary results for the year ended 31 Dec 2022 | 05-May-2023 | 07:00 | RNS |
Regulatory authorisation for Mevalone in Poland | 17-Apr-2023 | 07:00 | RNS |
US State Regulatory Approvals Update | 23-Mar-2023 | 07:00 | RNS |
First Mevalone authorisation for domestic use | 30-Jan-2023 | 07:00 | RNS |
Trading Update | 10-Jan-2023 | 07:00 | RNS |
Distribution Agreement for Mevalone in France | 15-Dec-2022 | 07:00 | RNS |
Organic Certification in Greece | 30-Nov-2022 | 07:00 | RNS |
AIM Rule 17 Notification | 24-Oct-2022 | 12:00 | RNS |
Holding(s) in Company | 03-Oct-2022 | 16:39 | RNS |
Eden Half Yearly Report | 30-Sep-2022 | 07:00 | RNS |
Appointment of Auditor | 28-Sep-2022 | 08:46 | RNS |
Eden granted US EPA regulatory approval | 26-Sep-2022 | 07:00 | RNS |
Appointment of Non-Executive Director | 02-Sep-2022 | 07:00 | RNS |
Trading Update | 22-Aug-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 4.13p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.85 |
52 Week Low | 3.40 |
Volume | 409,911 |
Shares Issued | 533.35m |
Market Cap | £22.00m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:25 | 5,112 @ 4.11p |
16:02 | 25,000 @ 4.00p |
15:42 | 16,350 @ 4.11p |
15:41 | 50,000 @ 4.11p |
13:13 | 48,873 @ 4.08p |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research